doctor filling out forms on clipboard

High-Enrolling Sites

Finding the right sites and well-qualified patients

If you’re enrolling a complex trial, you may struggle to recruit the patients you need. The average Phase III protocol has 87 sites across 14 countries and collects close to four million data points.1 Sites often struggle to meet difficult inclusion/exclusion and diversity criteria. Plus, managing multiple sites and vendors creates additional challenges of maintaining consistent performance.

world icon
0 +

AES provides access to more than 160 high-enrolling research sites throughout the world

AES Patients

Plan

Past performance provides confidence to predict future results

Identify

Advanced data modeling predicts the patients most likely to enroll

Recruit

Localized campaigns contact patients how they prefer to engage

Pre-screen

Centralized platform confirms eligibility consistently worldwide

Follow-up

Proactive site follow-up to support randomizing patients

AES Research Sites

Infrastructure icon

Infrastructure

Global footprint enables worldwide scale with a single site contract

people icon

People

Research-dedicated teams ensure patient safety and data quality

process icon

Process

Standardized global procedures deliver uniform conduct and quality globally

How we can help

With AES Sites & Patients, we offer a single, centrally managed solution that expands on our patient recruitment to recruit patients directly into AES research sites, delivering the number of patients needed from fewer sites.

AES provides access to more than 160 high-enrolling research sites throughout the world, with a focus on selecting sites for each study that will deliver the most qualified patients. Our extensive global footprint allows site scalability across a wide geographic reach and ensures consistent high quality based on standard operating procedures.

Strong global footprint to recruit and execute studies

three doctors icon
Experienced investigators and teams

Staffed by experienced investigators and teams dedicated exclusively to clinical research

fast startup times icon
Faster startup times

Faster startup times compared to industry average

icon extensive global site
Extensive global site services solution

Extensive global site services solution, including five continents, 16 countries and more than 160 sites throughout the world, purpose-built to support large volumes of patients

building icon
State-of-the-art facilities

State-of-the-art facilities designed for large volumes of study patients

person pin drop location icon
One contract

Centralized operations under one contract to simplify trial execution

Explore High-Enrolling Sites

Sources

  1. Tufts Center for the Study of Drug Development, Impact Report, January/February 2021